Quidel Corporation

Global Legionella Testing Market Report 2023-2027: Rise in Food Safety Concerns Boosts Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 5, 2023
Research, Infectious Diseases, Hospitals, Food, Beverage, Health, Agriculture, Retail, Natural Resources, Science, Other Science, TUV, Thermo Fisher Scientific, United States national laboratories, Quidel Corporation, SGS, Research, SA, UL LLC, Infection, Commonwealth Associates, Inc., UL, Laboratory, Intertek, Retail

This study identifies the emergence of new infectious diseases as one of the prime reasons driving the legionella testing market growth during the next few years.

Key Points: 
  • This study identifies the emergence of new infectious diseases as one of the prime reasons driving the legionella testing market growth during the next few years.
  • Also, technological advances in respiratory monitoring devices and increasing initiatives for rapid diagnostics of infectious diseases will lead to sizable demand in the market.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
  • The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Global Legionella Testing Market 2023-2027

Retrieved on: 
Wednesday, January 4, 2023
SA, Intertek, Food safety, Tourist Railway Association, Inc., Quidel Corporation, Infection, SGS, United States national laboratories, Laboratory, TUV, UL, Research, UL LLC, Thermo Fisher Scientific, Retail

Our report on the legionella testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Key Points: 
  • Our report on the legionella testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
  • The legionella testing market is segmented as below:
    This study identifies the emergence of new infectious diseases as one of the prime reasons driving the legionella testing market growth during the next few years.
  • Our report on the legionella testing market covers the following areas:
    This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading legionella testing market vendors that include AEMTEK Inc., Aerobiology Laboratory Associates Inc., Aquacert Ltd., Becton Dickinson and Co., bioMerieux SA, Eiken Chemical Co. Ltd., Element Materials Technology Group Ltd., EMSL Analytical Inc., Eurofins Scientific SE, IDEXX Laboratories Inc., Intertek Group Plc, Pace Analytical Services LLC, PDC Laboratories LLC, Pro Lab Diagnostics Inc., Quidel Corp., SGS SA, Thermo Fisher Scientific Inc., TUV NORD AG, UL LLC, and Bio Rad Laboratories Inc. Also, the legionella testing market analysis report includes information on upcoming trends and challenges that will influence market growth.

QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform

Retrieved on: 
Friday, December 16, 2022
Data Management, Medical Supplies, Biotechnology, Technology, Health, General Health, Pharmaceutical, Health Technology, Other Science, Medical Devices, Science, STAT, Immunoassay, Diagnosis, Nature, Security (finance), IVD, Greater China, Knowledge, Commission, Transfusion medicine, Runda, Quidel Corporation, Ortho, Automation, JV, Partnership, Ortho Clinical Diagnostics, Pharmaceutical industry, Medical device, Risk management

Runda Medical is a leading IVD distributor in China and has developed its own family of instruments and assays.

Key Points: 
  • Runda Medical is a leading IVD distributor in China and has developed its own family of instruments and assays.
  • The JV will leverage both parties know-how in a range of incremental assays to broaden the VITROS test menu and gain efficiencies from local manufacturing at Runda Medicals Shanghai facility.
  • Both companies will contribute personnel and expertise to the joint venture and will share in the profits of the jointly developed products.
  • Currently, Runda Medical has more than 50 holding subsidiaries, providing integrated laboratory services to more than 4,000 public medical institutions in China.

QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles

Retrieved on: 
Monday, December 12, 2022
Science, Biotechnology, Research, Health, Medical Devices, Data Management, Health Technology, Technology, Security (finance), IVD, Ortho Clinical Diagnostics, The Advisory Board Company, Point-of-care testing, Automation, Biomarker, Research, Alere, Knowledge, Quidel Corporation, Commission, Transfusion medicine, Pleasure, Immunoassay, Nature, Acquisition, Management, Medical device, Risk management

The separation of the Chairman and Chief Executive Officer roles is a key step toward strengthening the Companys governance practices and will facilitate the right balance between strong and consistent Company leadership and independent oversight by the Board.

Key Points: 
  • The separation of the Chairman and Chief Executive Officer roles is a key step toward strengthening the Companys governance practices and will facilitate the right balance between strong and consistent Company leadership and independent oversight by the Board.
  • The Board also appointed Douglas Bryant to serve as President, in addition to Mr. Bryants current role as Chief Executive Officer and a member of the Board.
  • He brings strategic oversight combined with a wealth of leadership and scientific industry expertise to our Board, said Mr. Bryant, President and Chief Executive Officer of QuidelOrtho.
  • Additionally, Robert J. Bujarski, Chief Operating Officer, and Michael S. Iskra, Chief Commercial Officer, have both been appointed to the newly created Executive Vice President roles, in addition to serving in their existing leadership roles.

The Global Lateral Flow Assay Components Market is expected to grow by $97.76 mn during 2023-2027, accelerating at a CAGR of 5.22% during the forecast period

Retrieved on: 
Tuesday, December 6, 2022
Thermo Fisher Scientific, Siemens, POC, Mayo Collaborative Services v. Prometheus Laboratories, Inc., Quidel Corporation, Hologic, Research, Bio-Techne, Abbott Laboratories, Sartorius AG, Merck Group, QIAGEN, PerkinElmer, Retail

View original content:https://www.prnewswire.com/news-releases/the-global-lateral-flow-assay-c...

Key Points: 
  • This study identifies the growing demand for point-of-care (POC) testing as one of the prime reasons driving the lateral flow assay components market growth during the next few years.
  • Also, evolving application of lateral flow assays and increasing public and private investment to develop lateral flow assays will lead to sizable demand in the market.
  • The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

QuidelOrtho to Host Investor Day on December 13, 2022

Retrieved on: 
Wednesday, November 30, 2022
Other Health, Research, General Health, Data Management, Medical Devices, Technology, Health Technology, Science, Biotechnology, Medical Supplies, Other Science, Health, IVD, Immunoassay, Ortho Clinical Diagnostics, Automation, Knowledge, Quidel Corporation, Learning Technology Partners, Interest, Transfusion medicine, Nasdaq MarketSite, Medical device, Online shopping

QuidelOrtho Corporation (Nasdaq: QDEL) (QuidelOrtho), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will host an Investor Day on Tuesday, December 13, 2022, starting at 1:00 p.m.

Key Points: 
  • QuidelOrtho Corporation (Nasdaq: QDEL) (QuidelOrtho), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will host an Investor Day on Tuesday, December 13, 2022, starting at 1:00 p.m.
  • ET / 10:00 a.m. PT at Convene at Nasdaq MarketSite, 151 West 42nd Street, New York, NY 10036.
  • This is the inaugural Investor Day following the combination of Quidel Corporation and Ortho Clinical Diagnostics in May 2022.
  • Interested parties can access the preregistration, live webcast and replay on the Events & Presentations section of the Investor Relations page of QuidelOrthos website at https://ir.quidelortho.com/ .

Global Self-Testing Kits Market Trends and Forecasts Report, 2019-2021 & 2022-2027 Featuring Major Manufacturers - Abbott, ACON Laboratories Inc., Roche, Assure Tech and AdvaCare Pharma - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 2, 2022
Infectious Diseases, Health, Medical Supplies, Other Health, Hoffmann-La Roche, Pregnancy, Infection, BD, Self-test of intelligence, HIV, Industry, Risk, COVID-19, Laboratory, Quidel Corporation, Incidence, Hangzhou, Dickinson, Technology, Company, Patient, Environment, COVID-19 testing, Diabetes, Animal, Medical device, Pharmaceutical industry, Fine chemical

The "Global Self-Testing Kits Market Trends and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Self-Testing Kits Market Trends and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • The current report will provide an in-depth look at the self-testing kits market.
  • This report analyzes the market trends of self-testing kits with data from 2021, estimates from 2022, and projections of compound annual growth rates (CAGRs) through 2027 (forecast period 2022-2027) and examines regional markets for self-testing kits.
  • Major manufacturers of self-testing kits include Abbott, ACON Laboratories Inc., Roche Holding AG, Assure Tech (Hangzhou) Co. Ltd. and AdvaCare Pharma LLP.

Infectious Respiratory Disease Diagnostics Market Report 2022: Rising R&D Investments In Respiratory Disease Testing Boost Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, October 31, 2022
Infectious Diseases, Biotechnology, Health, Quidel Corporation, Diagnosis, Application, USD, IVD, Danaher, Industry, UN, COVID-19 testing, RSV, D, Pneumonia, COVID-19, Disease, BD, Technology, Infection, Growth, Tuberculosis, Qiagen, Revenue, Prevalence, Incidence, Laboratory, Medical device, Pharmaceutical industry, Vaccine

The global infectious respiratory disease diagnostic market size is expected to reach USD 43.74 billion by 2030 according to a new study.

Key Points: 
  • The global infectious respiratory disease diagnostic market size is expected to reach USD 43.74 billion by 2030 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
  • For instance, in April 2020, 6.08 million people across globe were infected with COVID-19 diseases, which increased the need for rapid diagnostics testing is likely to boost the infectious respiratory disease diagnostic market.
  • The publisher has segmented the infectious respiratory disease diagnostics market report based on, technology, product, application, work-flow, end-use, and regions:
    Infectious Respiratory Disease Diagnostics, Product Type Outlook (Revenue - USD Billion, 2018 - 2030)

Medical Device Innovation Consortium (MDIC) Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics

Retrieved on: 
Wednesday, October 19, 2022
Research, Medical Devices, Genetics, Health Technology, Biotechnology, Health, Pharmaceutical, Science, Oncology, Horizon Discovery, Method, National Institute, CDC, NIST, Efficiency, SRS, Grant, Gaps, National Institute of Standards and Technology, Patient, Catalog, Data, Contract, Research, NIH, PerkinElmer, Cancer, Senior, SRSS, Partnership, National Philanthropic Trust, Discovery, NGS, CEO, Safety, CRISPR, MDIC, Gordon, Initiative, DNA, FDA, List of life sciences, Medical device, Medicine, Pharmaceutical industry, Technology, Illumina, Quidel Corporation

The Medical Device Innovation Consortium ( MDIC ) has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of next generation sequencing (NGS)-based cancer diagnostics.

Key Points: 
  • The Medical Device Innovation Consortium ( MDIC ) has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of next generation sequencing (NGS)-based cancer diagnostics.
  • These tools could be used for diagnostic development, regulatory submissions, reimbursement decisions, and other applications across the total product life cycle of NGS-based diagnostics.
  • Leveraging its rich heritage in CRISPR editing technologies, Horizon Discovery has used this process to develop cell-based reference material for over a decade.
  • Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle.

vybe urgent care Announces Its 15th Location - Radnor

Retrieved on: 
Monday, October 17, 2022
Insurance, Abington Township, Montgomery County, Pennsylvania, VP, Holiday, UCA, COVID, Bucks, Urgent Care Association, PCOM, Patient, Twitter, Newtown Township, Delaware County, Pennsylvania, Bryn Mawr, Instagram, Colorado EKG Repository, Occupational medicine, Mainline, Blue Bell, Safety, Quidel Corporation, Telehealth, Vybe Beatz, Philadelphia and Lancaster Turnpike, Travel, Spring Garden, Hospital, Vaccine, Facebook, Moderna, Delaware Valley

vybe's 15th urgent care center is located on Lancaster Avenue in the Radnor Hotel complex, at the intersection of Radnor-Chester Road.

Key Points: 
  • vybe's 15th urgent care center is located on Lancaster Avenue in the Radnor Hotel complex, at the intersection of Radnor-Chester Road.
  • Consumers rely on vybe urgent care centers for walk-in convenience, but vybe also offers appointments for all urgent care services.
  • vybe urgent care is Philadelphia's leading independent urgent care provider delivering care to adults and children in Philadelphia, Delaware, Bucks and Montgomery Counties.
  • vybe is fully accredited by the Urgent Care Association (UCA), which is the highest level of distinction for urgent care centers and ensures high levels of patient safety and quality.